Form 4: CorMedix Director Sells 40,000 Shares

CorMedix Inc. Director Steven W. Lefkowitz reported the sale of 40,000 shares of common stock at a weighted average price of $11.88 per share.

Summary

• Steven W. Lefkowitz, a Director of CorMedix Inc., sold 40,000 shares of common stock.
• The transaction occurred on December 9, 2025.
• The shares were sold at a weighted average price of $11.88, with individual trades ranging from $11.87 to $11.92.
• Following the sale, Mr. Lefkowitz directly owns 80,498 shares.
• He also indirectly owns 30,152 shares through Wade Capital Corporation Money Purchase Plan and 2,000 shares through his wife.

Sentiment

Score: 4

Explanation: The sale of shares by a director, while a routine disclosure, can sometimes be interpreted as a slightly negative signal regarding insider confidence, though it may also be for personal financial planning.

Negatives

• Director Steven W. Lefkowitz sold 40,000 shares of common stock, which could be interpreted by some investors as a negative signal regarding insider confidence.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders might interpret the director's sale as a signal, potentially influencing their perception of the stock.

Key Dates

Recommendation

The filing reports an insider sale by a director. While insider selling can sometimes be a bearish signal, a single transaction of this size by one director, without additional context on the company's financial health or strategic direction, is generally not sufficient to warrant a strong buy or sell recommendation. Investors should consider this information alongside other fundamental and technical analysis before making investment decisions.

Keywords

CorMedix, CRMD, insider trading, Form 4, stock sale, director, Steven W. Lefkowitz